Top Sell
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.62 | €3.00 | 382.315% |
| Waters Corp. | 0 | 3 | 0 | 0 | €298.00 | €253.83 | -14.824% |
| Bristol-Myers Squibb | 11 | 3 | 1 | 0 | €41.38 | €67.64 | 63.478% |
| Emergent Biosolutions Inc. | 2 | 3 | 1 | 2 | €2.90 | €4.62 | 59.207% |
| ViewRay Inc | 0 | 3 | 0 | 0 | €0.025 | - | - |
| Agenus Inc. | 2 | 3 | 0 | 0 | €0.41 | €7.30 | 1664.911% |
| Elanco Animal Health Inc. | 6 | 3 | 0 | 0 | €12.33 | €15.50 | 25.783% |
| Sage Therapeutics Inc. | 5 | 3 | 1 | 1 | €13.05 | €26.71 | 104.711% |
| Integra LifeSciences Holdings Corp | 3 | 3 | 0 | 0 | €27.20 | €45.73 | 68.128% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €2.93 | - | - |
| Palatin Technologies Inc. | 0 | 4 | 0 | 0 | €1.71 | - | - |
| Pfizer Inc. | 30 | 4 | 2 | 1 | €25.32 | €41.29 | 63.063% |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €6.15 | €7.00 | 13.821% |
| Fibrogen Inc. | 1 | 4 | 0 | 1 | €0.95 | €0.000 | -100.000% |
| Illumina Inc. | 17 | 4 | 2 | 1 | €118.16 | €177.57 | 50.283% |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 1 | €2.26 | €7.00 | 209.735% |
| Ionis Pharmaceuticals Inc. | 17 | 5 | 4 | 0 | €40.24 | €56.86 | 41.307% |
| Pacific Biosciences of California Inc. | 10 | 5 | 3 | 2 | €1.68 | €10.20 | 507.495% |
| Ocular Therapeutix Inc. | 7 | 5 | 0 | 1 | €4.74 | €11.40 | 140.557% |
| Organovo Holdings Inc. | 0 | 5 | 0 | 0 | €0.88 | €3.00 | 240.909% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.86 | €8.82 | 927.458% |
| BioLase Inc. | 0 | 6 | 0 | 1 | €0.067 | - | - |
| CEL-SCI Corp. | 0 | 6 | 0 | 0 | €1.31 | - | - |
| Avinger Inc. | 2 | 7 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| T2 Biosystems Inc. | 0 | 12 | 0 | 0 | €0.16 | - | - |